Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation.

通过第二次立体定向心律失常放射消融治疗难治性室性心动过速。

• 影响指数: 4.739
• 发表时间: Nov 2022
• 来源期刊: Clin Transl Radiat Oncol
• DOI: 10.1016/j.ctro.2022.07.005
• PMID: 36118122
• 文章类型: Case Reports
• 作者列表: Herrera Siklody C,Pruvot E,Pascale P,Kinj R,Jumeau R,Le Bloa M,Teres C,Domenichini G,Porretta AP,Ozsahin M,Bourhis J,Schiappacasse L,Herrera Siklody C,Pruvot E,Pascale P,Kinj R,Jumeau R,Le Bloa M,Teres C,Domenichini G,Porretta AP,Ozsahin M,Bourhis J,Schiappacasse L

关键词: Ischemic heart disease; Non-ischemic cardiomyopathy; Stereotactic arrhythmia radioablation (STAR); ventricular tachycardia (VT); Ischemic heart disease; Non-ischemic cardiomyopathy; Stereotactic arrhythmia radioablation (STAR); ventricular tachycardia (VT)

Abstract

UNASSIGNED: Stereotactic arrhythmia radioablation (STAR) is an effective treatment for refractory ventricular tachycardia (VT), but recurrences after STAR were recently published. Herein, we report two cases of successful re-irradiation of the arrhythmogenic substrate.
UNASSIGNED: We present two cases of re-irradiation after recurrence of a previously treated VT with radioablation at a dose of 20 Gy. The VT exit was localized on the border zone of the irradiated volume, which responded positively to re-irradiation at follow-up.
UNASSIGNED: These two cases show the technical feasibility of re-irradiation to control recurrent VT after a first STAR.

摘要

未经证实：立体定向心律失常放射消融（STAR）是难治性室性心动过速（VT）的有效治疗方法，但在最近发表STAR之后复发。在这里，我们报告了2例成功再次照射致心律失常基质的病例。
UNASSIGNED：我们介绍了2例先前治疗过的室性心动过速复发后再次放疗的病例，剂量为20Gy。室性心动过速出口位于照射体积的边界区域，在随访时对再照射反应积极。
UNASSIGNED：这两种情况显示了在第一次STAR后重新照射以控制复发性VT的技术可行性。